Ordering Publications
To order a hard copy of any of the publications listed below from UCLA ISAP, send the article number (found at the end of the reference, for example "12.1"), the article author/title, and your postal address to:
Kris Langabeer
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Ste. 200
Los Angeles, CA 90025-7535
Your first 5 articles ordered per year are free, but additional articles are $1 per reprint. Checks should be made out to "UC Regents." Purchase orders will not be accepted for orders under $25.
Publications List (A-C)
(A list of all publications is available as an .rtf file).
Adams, E., Brodsky, M., Gropper, B., & Anglin, M. D. (1988).
Interagency workshop-conference on prevalence estimation techniques.
Unpublished manuscript, University of California, Los Angeles,
Drug Abuse Research Center. (12.1)
Adler, L. E., Olincy, A., Cawthra, E., Hoffer, M., Nagamoto, H.
T., Amass, L., & Freedman, R. (2001). Reversal of diminished
inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic
mechanism. Neuropsychopharmacology, 24(6), 671-679. (04.44)
Alessi, S. M., Roll, J. M., Reilly, M. P., & Johanson, C.
E. (2002). Establishment of a diazepam preference in human volunteers
following a differential-conditioning history of placebo versus
diazepam choice. Experimental and Clinical Psychopharmacology,
10(2), 77-83. (27.15)
Alessi, S. M., Roll, J. M., Reilly, M. P., & Johanson, C.
E. (2002). Establishment of a diazepam preference in human volunteers
following a differential-conditioning history of placebo versus
diazepam choice: Reply to Bouton (2002), Carroll (2002), Chilcoat
(2002), Kelly (2002), Stewart (2002), and Vuchinich (2002). Experimental
and Clinical Psychopharmacology, 10(2), 101-103. (27.16)
Almog, Y. J., Anglin, M. D., & Fisher, D. G. (1993). Alcohol
and heroin use patterns of narcotics addicts: Gender and ethnic
differences. American Journal of Drug and Alcohol Abuse, 19(2),
219-238. (02.7)
Amass, L., Bickel, W. K., Crean, J. P., Blake, J., & Higgins,
S. T. (1998). Alternate-day buprenorphine dosing is preferred
to daily dosing by opioid-dependent humans. Psychopharmacology,
136(3), 217-225. (29.4)
Amass, L., Bickel, W. K., Crean, J. P., & Higgins, S. T. (1996).
Preferences for clinic privileges, retail items and social activities
in an outpatient buprenorphine treatment program. Journal
of Substance Abuse Treatment, 13(1), 43-49. (29.3)
Amass, L., Bickel, W. K., Higgins, S. T., & Badger, G. J.
(1994). Alternate-day dosing during buprenorphine treatment of
opioid dependence. Life Sciences, 54(17), 1215-1228.
(29.11)
Amass, L., Bickel, W. K., Higgins, S. T., Budney, A. J., &
Foerg, F. E. (1993). The taking of free condoms in a drug abuse
treatment clinic: The effects of location and posters. American
Journal of Public Health, 83(10), 1466-1468. (18.96)
Amass, L., Bickel, W. K., Higgins, S. T., & Hughes, J. R.
(1994). A preliminary investigation of outcome following gradual
or rapid buprenorphine detoxification. Journal of Addictive
Diseases, 13(3), 33-45. (29.14)
Amass, L., Kamien, J. B., & Mikulich, S. K. (2000). Efficacy
of daily and alternate-day dosing regimens with the combination
buprenorphine-naloxone tablet. Drug and Alcohol Dependence,
58(1-2), 143-152. (29.1)
Amass, L., Kamien, J. B., & Mikulich, S. K. (2001). Thrice-weekly
supervised dosing with the combination buprenorphine-naloxone
tablet is preferred to daily supervised dosing by opioid-dependent
humans. Drug and Alcohol Dependence, 61(2), 173-181.
(29.2)
Amass, L., Nardin, R., Mendelson, J. H., Teoh, S. K., & Woods,
B. T. (1992). Quantitative magnetic resonance imaging in heroin-
and cocaine-dependent men: A preliminary study. Psychiatry
Research: Neuroimaging, 45(1), 15-23. (29.13)
Aneshensel, C., Anglin, M. D., Brown, R., Cousineau, M., Dallek,
G., Fiorentine, R., Freed, J., Halfon, N., Leslie, J., Pollack,
S., Pridgen, J., Sorenson, S., Upchurch, D., Visscher, B., &
Wallace, S. (1993). Inequalities in health: "The sickness
in the center of our cities". In: A. J. Scott, & R. Brown
(Eds.), South-Central Los Angeles: Anatomy of an urban crisis
(pp. 43-88). Los Angeles: Lewis Center for Regional Policy Studies.
(13.8)
Angell, J. L. (1993). Initial process evaluation and participant
profile of the Bay Area Services Network (BASN). Unpublished manuscript,
California Department of Corrections: (06.34)
Anglin, M. D. (1982). Alcohol and criminality. In: E. M. Pattison,
& E. Kaufman (Eds.), Encyclopedia handbook of alcoholism
(pp. 383-394). New York: Gardner Press. (02.1)
Anglin, M. D. (1987). Book reviews [Review of the book Alcohol
and aggression, 2nd edition]. Journal of Studies of Alcohol,
48(3), 281-282. (02.3)
Anglin, M. D. (1984). Book reviews [Review of the book Alcohol,
drug abuse and aggression, 2nd edition]. Journal of Studies
of Alcohol, 45(5), 469. (02.2)
Anglin, M. D. (1989). Civil commitment as a model for reducing
drug demand. In: J. Scher, & M. Segal (Eds.), Perspectives
in Drug Abuse, Vol. 1 (pp. 225-235). London: Freund Publishing
House, Ltd. (03.7)
Anglin, M. D. (1989). Compulsory treatment for opiate dependence:
Reviews of findings and social policy implications. Unpublished
manuscript, University of California, Los Angeles, Drug Abuse
Research Center. (18.6)
Anglin, M. D. (1994). Drug use and crime. In: A. J. Lurigio, &
G. J. Bensinger (Eds.), Drugs and community corrections
(pp. 85-94). Chicago: Loyola University. (06.20)
Anglin, M. D. (1988). The efficacy of civil commitment in treating
narcotic addiction. In: C. G. Leukefeld, & F. M. Tims (Eds.),
Compulsory treatment of drug abuse: Research and clinical
practice (NIDA Research Monograph 86, pp. 8-34). Rockville,
MD: National Institute on Drug Abuse. (03.5)
Anglin, M. D. (1990). Ensuring success in corrections-based interventions
with drug-abusing populations. Unpublished manuscript, University
of California, Los Angeles, Drug Abuse Research Center. (06.10)
Anglin, M. D. (1995). A methodological review of the California
Drug and Alcohol Treatment Assessment (CALDATA) study. Unpublished
manuscript, University of California, Los Angeles, Drug Abuse
Research Center. (18.35)
Anglin, M. D. (1990). Raising children in the twenty-first century:
Drug abuse treatment to ameliorate negative family and childhood
effects of parental drug abuse. Paper presented at "A seminar
for executive branch employees", sponsored by the American
Enterprise Institute for Public Policy Research, Williamsburg,
VA. (11.4)
Anglin, M. D. (1988). A social policy analysis of compulsory treatment
for opiate dependence. Journal of Drug Issues, 13(4).
(18.5)
Anglin, M. D. (1986). Special section: Developments, trends and
prospects in substance abuse. Journal of Drug Education, 16(3),
263. (13.1)
Anglin, M. D., Almog, Y. J., Fisher, D. G., & Peters, K. (1989).
Alcohol use by heroin addicts: Evidence for an inverse relationship.
A study of methadone maintenance and drug-free treatment samples.
American Journal of Drug and Alcohol Abuse, 15(2), 191-207.
(02.4)
Anglin, M. D., Belmont, A., & Boyle, K. (1988). Etiological
and epidemiological aspects of drug abuse. Paper presented at
the Drug Abuse Information and Monitoring Project: AIDS outreach
pilot demonstration project for neighborhood outreach workers.
(08.1)
Anglin, M. D., Booth, M. W., Kao, C. F., Harlow, L. L., &
Peters, K. (1987). Similarity of behavior within addict couples.
Part II. Addiction-related variables. International Journal
of the Addictions, 22(7), 583-607. (14.1)
Anglin, M. D., Booth, M. W., Ryan, T. M., & Hser, Y. (1988).
Ethnic differences in narcotics addiction. Part II. Chicano and
Anglo addiction career patterns. International Journal of
the Addictions, 23(10), 1011-1027. (09.1)
Anglin, M. D., & Brecht, M. L. (1987). AIDS virus exposure
in long term addicts: A preliminary study. In: L. S. Harris (Ed.),
Problems of drug dependence 1986: Proceedings of the 48th
annual scientific meeting, the College on Problems of Drug Dependence,
Inc. (NIDA Research Monograph 76, pp. 200-206). Rockville,
MD: National Institute on Drug Abuse. (01.1)
Anglin, M. D., Brecht, M. L., & Maddahian, E. (1989). Pretreatment
characteristics and treatment performance of legally coerced versus
voluntary methadone maintenance admissions. Criminology, 27(3),
537-557. (18.10)
Anglin, M. D., Brecht, M. L., Woodward, J. A., & Bonett, D.
G. (1986). An empirical study of maturing out: Conditional factors.
International Journal of the Addictions, 21(2), 233-246.
(18.2)
Anglin, M. D., Caulkins, J. P., & Hser, Y. (1993). Prevalence
estimation: Policy needs, current status and future potential.
Journal of Drug Issues, 23(2), 345-360. (12.23)
Anglin, M. D., Danila, B., Ryan, T. M., & Mantius, K. (1996).
Staying in touch: A fieldwork manual of tracking procedures for
locationg substance abusers for follow-up studies. Washington,
D.C.: National Evaluation Data and Technical Assistance Center
(NEDTAC). (20.13)
Anglin, M. D., Deschenes, E. P., & Prendergast, M. L. (1994).
Ethnic and gender differences in effectiveness of legal supervision
in controlling narcotics use and crime. Unpublished manuscript,
University of California, Los Angeles, Drug Abuse Research Center.
(09.9)
Anglin, M. D., Deschenes, E. P., & Speckart, G. R. (1988).
Optimization of legal supervision for chronic addict offenders:
Final report. Unpublished manuscript, University of California,
Los Angeles, Drug Abuse Research Center. (10.7)
Anglin, M. D., & Fisher, D. G. (1987). Survival analysis in
drug program evaluation. Part II. Partitioning treatment effects.
International Journal of the Addictions, 22(4), 377-387.
(16.1)
Anglin, M. D., & Hser, Y. (1988). Addict career histories:
Processes and patterns. Unpublished manuscript, University of
California, Los Angeles, Drug Abuse Research Center. (16.3)
Anglin, M. D., & Hser, Y. (1987). Addicted women and crime.
Criminology, 25(2), 359-397. (21.1)
Anglin, M. D., & Hser, Y. (1990). Concept paper on improving
measures for better estimation of drug abuse prevalence and consequences.
Paper prepared for the Bureau of Justice Statistics/RAND Seminar,
Washington, DC. (12.4)
Anglin, M. D., & Hser, Y. (1991). Criminal justice and the
drug-abusing offender: Policy issues of coerced treatment. Behavioral
Sciences and the Law, 9(3), 243-267. (06.14)
Anglin, M. D., & Hser, Y. (1992). Drug abuse treatment. In:
R. R. Watson (Ed.), Drug and alcohol abuse reviews, Vol. 4
(pp. 1-36). Totowa, NJ: Humana Press. (18.21)
Anglin, M. D., & Hser, Y. (1990). Legal coercion and drug
abuse treatment: Research findings and social policy implications.
In: J. A. Inciardi (Ed.), Handbook of drug control in the
United States (pp. 151-176). Westport, CT: Greenwood Press.
(18.12)
Anglin, M. D., & Hser, Y. (1996). Outcome evaluation research.
In: Drug abuse and drug abuse research: The fourth triennial
report to congress from the secretary, Department of Human Services
(pp. 3-1--3-7). Rockville, MD: National Institute of Drug Abuse.
(13.6)
Anglin, M. D., & Hser, Y. (1991). Overview and summary of
meeting. Paper presented at the Proceedings of the Prevalence
Estimation Methods Workshop. Washington, DC: National Institute
of Justice; Rockville, MD: National Institute on Drug Abuse. (12.8)
Anglin, M. D., & Hser, Y. (1990). Treatment of drug abuse.
In: M. Tonry, & J. Q. Wilson (Eds.), Drugs and crime,
Vol. 13 (pp. 393-460). Chicago: University of Chicago Press.
(18.13)
Anglin, M. D., Hser, Y., & Booth, M. W. (1987). Sex differences
in addict careers. 4. Treatment. American Journal Of Drug
And Alcohol Abuse, 13(3), 253-280. (14.2)
Anglin, M. D., Hser, Y., Booth, M. W., Speckart, G. R., McCarthy,
W. J., Ryan, T. M., & Powers, K. I. (1988). The natural history
of narcotics addiction: A 25 year follow-up. Unpublished manuscript,
University of California, Los Angeles, Drug Abuse Research Center.
(03.6)
Anglin, M. D., Hser, Y., Brecht, M. L., Deschenes, E. P., Rodriguez,
M. E., Speckart, G. R., Booth, M. W., & Powers, K. I. (1989).
Summary of recent research findings. Unpublished manuscript, University
of California, Los Angeles, Drug Abuse Research Center. (13.2)
Anglin, M. D., Hser, Y., & Chou, C. P. (1993). Reliability
and validity of retrospective behavioral self-report by narcotics
addicts. Evaluation Review, 17(1), 91-108. (12.12)
Anglin, M. D., Hser, Y., & Grella, C. E. (1997). Drug addiction
and treatment careers among clients in DATOS. Psychology of
Addictive Behaviors, 11(4). (18.57)
Anglin, M. D., Hser, Y., Grella, C. E., Longshore, D., & Prendergast,
M. L. (1997). Drug treatment careers: Conceptual overview and
application to DATOS. Unpublished manuscript, University of California,
Los Angeles, Drug Abuse Research Center: (18.52)
Anglin, M. D., Hser, Y., Grella, C. E., Longshore, D., & Prendergast,
M. L. (2001). Drug treatment careers: Conceptual overview and
clinical, research, and policy applications. In: J. Platt, C.
G. Leukefeld, & F. M. Tims (Eds.), Relapse and recovery
processes in the addictions. New Haven, CT: Yale University
Press. (18.70)
Anglin, M. D., Hser, Y., & McGlothlin, W. H. (1987). Sex differences
in addict careers. 2. Becoming addicted. American Journal
of Drug and Alcohol Abuse, 13(1-2), 59-71. (14.3)
Anglin, M. D., Huba, G. J., & Ziedonis, D. (1989). White paper
on substance abuse research, training, and services at UCLA. Unpublished
manuscript, University of California, Los Angeles, Drug Abuse
Research Center: (13.3)
Anglin, M. D., Kalechstein, A., Maglione, M. A., Annon, J. J.,
& Fiorentine, R. (1998). Epidemiology and treatment of methamphetamine
abuse in California: A regional report. Unpublished report, University
of California, Los Angeles, Drug Abuse Research Center.: (18.68)
Anglin, M. D., Kao, C. F., Harlow, L. L., Peters, K., & Booth,
M. W. (1987). Similarity of behavior within addict couples. Part
I. Methodology and narcotics patterns. International Journal
of the Addictions, 22(6), 497-524. (14.4)
Anglin, M. D., Kaplan, J., & Sells, S. B. (1983). Drugs and
crime: Behavioral aspects. In: S. H. Kadish (Ed.), Encyclopedia
of crime and justice, Vol. 2 (pp. 636-643). New York: Free
Press. (06.2)
Anglin, M. D., Longshore, D., & Turner, S. (1999). Treatment
alternatives to street crime: An evaluation of five programs.
Criminal Justice and Behavior, 26(2), 168-195. (06.36)
Anglin, M. D., & Maugh, T. H. (1992). Ensuring success in
interventions with drug-using offenders. Annals, AAPSS, 521,
66-90. (06.18)
Anglin, M. D., & Maugh, T. H. (1992). Overturning myths about
coerced drug treatment. California Psychologist, 19-22.
(18.22)
Anglin, M. D., & McGlothlin, W. H. (1985). Methadone maintenance
in California: A decade's experience. In: L. Brill, & C. Winick
(Eds.), The yearbook of substance use and abuse, Vol. III
(pp. 219-280). New York : Humana Sciences Press. (10.6)
Anglin, M. D., & McGlothlin, W. H. (1984). Outcome of narcotic
addict treatment in California. In: F. M. Tims, & J. P. Ludford
(Eds.), Drug abuse treatment evaluation: Strategies, progress,
and prospects (NIDA Research Monograph 51, pp. 106-128).
Rockville, MD: National Institute on Drug Abuse. (18.1)
Anglin, M. D., McGlothlin, W. H., & Speckart, G. R. (1981).
The effect of parole on methadone patient behavior. American
Journal of Drug and Alcohol Abuse, 8(2), 153-170. (10.4)
Anglin, M. D., Miller, M. L., Mantius, K., & Grella, C. E.
(1993). Enhanced methadone maintenance treatment: Limiting the
spread of HIV among high risk Los Angeles narcotics addicts. In:
J. A. Inciardi, F. M. Tims, & B. W. Fletcher (Eds.), Innovative
approaches in the treatment of drug abuse: Program models and
strategies (pp. 3-19). Westport, CT: Greenwood Press. (10.13)
Anglin, M. D., & Perrochet, B. (1998). Drug use and crime:
A historical review of research conducted by the UCLA Drug Abuse
Research Center. Substance Use and Misuse, 33(9), 1871-1914.
(06.22)
Anglin, M. D., & Powers, K. I. (1990). Individual and joint
effects of methadone maintenance and legal supervision on the
behavior of narcotics addicts. Unpublished manuscript, University
of California, Los Angeles, Drug Abuse Research Center. (10.10)
Anglin, M. D., & Powers, K. I. (1991). Methadone treatment
and legal supervision: Individual and joint effects on the behavior
of narcotics addicts. Special issue: Individuals and organizations.
Journal of Applied Behavioral Science, 27(4), 515-531.
(10.11)
Anglin, M. D., Prendergast, M. L., & Longshore, D. (1994).
Nationwide TASC evaluation: Context, research objectives, and
study design. Paper presented at the annual meeting, American
Society of Criminology, Miami, FL. (18.25)
Anglin, M. D., Ryan, T. M., Booth, M. W., & Hser, Y. (1988).
Ethnic differences in narcotics addiction. I. Characteristics
of Chicano and Anglo methadone maintenance clients. International
Journal of the Addictions, 23(2), 125-149. (09.2)
Anglin, M. D., Shen, H., Hser, Y., & Brecht, M. L. Drug use
prevalence estimates among adult arrestees in California, Texas,
and the U.S. Final report submitted to the National Evaluation
and Data Technical Assistance Center, CSAT. Los Angeles, CA: UCLA
Drug Abuse Research Center. (08.8)
Anglin, M. D., & Speckart, G. R. (1988). Narcotics use and
crime: A multisample, multimethod analysis. Criminology, 26(2),
197-233. (06.7)
Anglin, M. D., & Speckart, G. R. (1986). Narcotics use, property
crime, and dealing: Structural dynamics across the addiction career.
Journal of Quantitative Criminology, 2(4), 355-375. (06.4)
Anglin, M. D., Speckart, G. R., Booth, M. W., & Ryan, T. M.
(1989). Consequences and costs of shutting off methadone. Addictive
Behaviors, 14(3), 307-326. (10.8)
Anglin, M. D., Speckart, G. R., & Deschenes, E. P. (1990).
Reexamining the effects of probation and parole on narcotics addiction
and property crime. Unpublished manuscript, University of California,
Los Angeles, Drug Abuse Research Center. (06.11)
Anglin, M. D., Thompson, J. P., & Fisher, D. G. (1986). Parental,
personality, and peer correlates of psychoactive mushroom use.
Journal of Drug Education, 16(3), 265-285. (11.1)
Anglin, M. D., & Urada, D. (2003). The California Substance
Abuse Research Consortium: Origins, history, and issues. Journal
of Psychoactive Drugs, SARC Supplement 1, 109-117. (13.43)
Anglin, M. D., Weisman, C. P., & Fisher, D. G. (1989). The
MMPI profiles of narcotics addicts. I. A review of the literature.
International Journal of the Addictions, 24(9), 867-880.
(13.4)
Anglin, M. D., & Westland, C. A. (1989). Drug monitoring in
the workplace: Results from the California commercial laboratory
drug testing project. In: S. W. Gust, & J. M. Walsh (Eds.),
Drugs in the workplace: Research and evaluation data
(NIDA Research Monograph 91, pp. 81-96). Rockville, MD: National
Institute on Drug Abuse. (22.1)
Annon, K., & Anglin, M. D. (1996). Update on illicit drug
use in Los Angeles County. Paper presented at the semi-annual
meeting, Community Epidemiology Work Group, New York, NY. (08.2)
Annon, K., & Anglin, M. D. (1996). Update on illicit drug
use in Los Angeles County. Paper presented at the semi-annual
meeting, Community Epidemiology Workgroup, Los Angeles, CA.: (08.4)
Annon, K., Hoffman, V., & Anglin, M. D. (1998). Update on
illicit drug use in Los Angeles County. Paper presented at the
semi-annual meeting, Community Epidemiology Work Group, Los Angeles,
CA. (08.7)
Annon, K., Hoffman, V., & Anglin, M. D. (1999). Update on
illicit drug use in Los Angeles County. Paper presented at the
semi-annual meeting, Community Epidemiology Workgroup, Los Angeles,
Ca.: (08.3)
Bailey, R. C., & Berg, D. (1994). The behavioral and attitudinal
modification project (BAM): A failed experiment using a classical
experimental research design in a closed institutional setting
for drug addicts. International Journal of the Addictions,
29(10), 1315-1345. (13.7)
Bailey, R. C., Hser, Y., Hsieh, S., & Anglin, M. D. (1994).
Influences affecting maintenance and cessation of narcotics addiction.
Special issue: Drugs and crime revisited. Journal of Drug
Issues, 24(2), 249-272. (18.32)
Baldwin, D. M., Brecht, M. L., Monahan, G., Annon, K., & Anglin,
M. D. (1995). Perceived need for treatment among pregnant and
non-pregnant women arrestees. Unpublished manuscript, University
of California, Los Angeles, Drug Abuse Research Center. (21.15)
Bartzokis, G., Beckson, M., Hance, D. B., Lu, P. H., Foster, J.
A., Mintz, J., Ling, W., & Bridge, P. (1999). Magnetic resonance
imaging evidence of "silent" cerebrovascular toxicity
in cocaine dependence. Biological Psychiatry, 45(9),
1203-1211. (04.46)
Bartzokis, G., Beckson, M., & Ling, W. (1996). Clinical and
MRI evaluation of psychstimulant neurotoxicity. In: Neurotoxicity
and neuropathology associated with cocaine abuse (NIDA Research
Monograph 163, pp. 300-317). Rockville, MD: National Institute
on Drug Abuse. (18.102)
Bartzokis, G., Beckson, M., Newton, T., Mandelkern, M. A., Mintz,
J., Foster, J. A., Ling, W., & Bridge, T. P. (1999). Selegiline
effects on cocaine-induced changes in medial temporal lobe metabolism
and subjective ratings of euphoria. Neuropsychopharmacology,
20(6), 582-590. (04.43)
Bartzokis, G., Lu, P. H., Beckson, M., Rapoport, R., Grant, S.,
Wiseman, E. J., & London, E. D. (2000). Abstinence from cocaine
reduces high-risk responses on a gambling task. Neuropsychopharmacology,
22(1), 102-103. (04.48)
Beck, J. E. (1987). MDMA. Los Angeles: Drug Abuse Information
and Monitoring Project, UCLA Drug Abuse Research Center. (20.2)
Bickel, W. K., & Amass, L. (1995). Buprenorphine treatment
of opioid dependence: A review. Experimental and Clinical
Psychopharmacology, 3(4), 477-489. (29.16)
Bickel, W. K., & Amass, L. (1993). The relationship of mean
daily blood alcohol levels to admission mast, clinic absenteeism
and depression in alcoholic methadone patients. Drug and Alcohol
Dependence, 32(2), 113-118. (02.15)
Bickel, W. K., Amass, L., Crean, J. P., & Badger, G. J. (1999).
Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent
patients. Psychopharmacology, 146(2), 111-118. (29.5)
Bickel, W. K., Amass, L., Higgins, S. T., Badger, G. J., &
Esch, R. A. (1997). Effects of adding behavioral treatment to
opioid detoxification with buprenorphine. Journal of Consulting
and Clinical Psychology, 65(5), 803-810. (29.15)
Bing, E. G., Burnam, A., Longshore, D., Fleishman, J. A., Sherbourne,
C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello,
B., Morton, S. C., Orlando, M., Bozzette, S. A., Ortiz-Barron,
L., & Shapiro, M. F. (2001). Psychiatric disorders and drug
use among human immunodeficiency virus-infected adults in the
United States. Archives of General Psychiatry, 58(8),
721-728. (01.57)
Bluthenthal, R. N., Gogineni, A., Longshore, D., & Stein,
M. D. (2001). Factors associated with readiness to change drug
use among needle-exchange users. Drug and Alcohol Dependence,
62(3), 225-230. (01.56)
Boles, S. M., Casas, J. M., Furlong, M., & Gonzalez, G. (1994).
Alcohol and other drug use patterns among Mexican-American, Mexican,
and Caucasian adolescents: New directions for assessment and research.
Journal of Clinical Child Psychology, 23(1), 39-46. (02.10)
Boles, S. M., & Johnson, P. B. (2001). Gender, weight concerns,
and adolescent smoking. Journal of Addictive Diseases, 20(2),
5-14. (14.13)
Boles, S. M., & Johnson, P. B. (2001). Violence among comorbid
and noncomorbid severely mentally ill adults: A pilot study. Substance
Abuse, 22(3), 167-173. (15.10)
Boles, S. M., & Miotto, K. (2003). Substance abuse and violence:
A review of the literature. Aggression and Violent Behavior,
8, 155-174. (13.42)
Bonson, K. R., Grant, S., Contoreggi, C., Links, J. M., Metcalfe,
J., Weyl, H. L., Kurian, V., Ernst, M., & London, E. D. (2002).
Neural systems and cue-induced cocaine craving. Neuropsychopharmacology,
26(3), 376-386. (30.6)
Booth, M. W., & Anglin, M. D. (1990). Mortality and morbidity
in narcotics addicts: A review of the literature. Unpublished
manuscript, University of California, Los Angeles, Drug Abuse
Research Center. (16.4)
Booth, M. W., Castro, P. G., & Anglin, M. D. (1991). What
do we know about Hispanic substance abuse? A review of the literature.
In: J. W. Moore, & R. Glick (Eds.), Drug use in Hispanic
communities (pp. 21-43). New Brunswick, NJ: Rutgers University
Press. (09.4)
Boyle, K., & Anglin, M. D. (1992). "To the curb":
Sex bartering and drug use among homeless crack users in Los Angeles.
In: M. Ratner (Ed.), Crack pipe as pimp: Sex for crack in
eight cities (pp. 159-186). New York: Lexington Press. (04.10)
Boyle, K., Gil-Rivas, V., & Anglin, M. D. (1994). Qualitative
evaluation of Buenacare's enhanced methadone treatment program.
Unpublished manuscript, University of California, Los Angeles,
Drug Abuse Research Center . (10.18)
Boyle, K., Polinsky, M. L., & Hser, Y. (2000). Resistance
to drug abuse treatment: a comparison of drug users who accept
or decline treatment referral assessment. Journal of Drug
Issues, 30(3), 555-574. (18.91)
Brecht, M. L., & Anglin, M. D. (1990). Conditional factors
of maturing out: Legal supervision and treatment. International
Journal of the Addictions, 25(4), 393-407. (18.14)
Brecht, M. L., & Anglin, M. D. (1992). Conditional factors
of maturing out of narcotic addiction: Long term relationships.
Unpublished manuscript, University of California, Los Angeles,
Drug Abuse Research Center. (18.3)
Brecht, M. L., Anglin, M. D., & Lu, T. H. (2003). Estimating
drug use prevalence among arestees using ADAM data: An application
of a logistic regression synthetic estimation procedure. Los Angeles:
UCLA Integrated Substance Abuse Programs. Available online from
the National Criminal Justice Reference Service (Document No.
198829) at http://www.ncjrs.org/pdffiles1/nij/grants/198829.pdf.
(12.26)
Brecht, M. L., Anglin, M. D., & Wang, J. C. (1993). Treatment
effectiveness for legally coerced versus voluntary methadone maintenance
clients. American Journal of Drug and Alcohol Abuse, 19(1),
89-106. (18.24)
Brecht, M. L., Anglin, M. D., Woodward, J. A., & Bonett, D.
G. (1987). Conditional factors of maturing out: Personal resources
and preaddiction sociopathy. International Journal of the
Addictions, 22(1), 55-69. (18.4)
Brecht, M. L., Hser, Y., & Anglin, M. D. (1990-1991). A multimethod
assessment of social intervention effects on narcotics use and
property crime. International Journal of the Addictions, 25(11A),
1317-1340. (06.13)
Brecht, M. L., Ritvo, E., Arnold, J., & Anglin, M. D. (1987).
Acquired immune deficiency syndrome: A review of the literature.
Los Angeles: Drug Abuse Information and Monitoring Project, UCLA
Drug Abuse Research Center. (01.2)
Brecht, M. L., & von Mayrhauser, C. L. (2002). Difference
between Ecstasy-using and nonusing methamphetamine users. Journal
of Psychoactive Drugs, 34(2), 215-223. (28.13)
Brecht, M. L., von Mayrhauser, C. L., & Anglin, M. D. (2000).
Predictors of relapse after treatment for methamphetamine use.
Journal of Psychoactive Drugs, 32(2), 211-220. (28.1)
Brecht, M. L., & Wickens, T. D. (1993). Application of multiple-capture
methods for estimating drug use prevalence. Journal of Drug
Issues, 23(2), 229-250. (12.17)
Brody, A. L., Mandelkern, M. A., London, E. D., Childress, A.
R., Lee. G.S., Bota, R. G., Ho, M. L., Saxena, S., Baxter, L.
R., Madsen, D., & Jarvik, M. E. (2002). Brain metabolic changes
during cigarette craving. Archives of General Psychiatry,
59, 1162-1172. (30.20)
Brower, K. J., & Anglin, M. D. (1987). Adolescent cocaine
use: Epidemiology, risk factors, and prevention. Journal of
Drug Education, 17(2), 163-180. (04.2)
Brown, A. H., Grella, C. E., & Cooper, L. (2002). Living it
or learning it: attitudes and beliefs about experience and expertise
in treatment for the dually diagnosed. Contemporary Drug Problems,
29, 687-710. (15.15)
Budney, A. J., Bickel, W. K., & Amass, L. (1998). Marijuana
use and treatment outcome among opioid-dependent patients. Addiction,
93(4), 493-503. (29.10)
Burdon, W. M., & Gallagher, C. A. (2002). Coercion and sex
offenders: controlling sex-offending behavior through incapacitation
and treatment. Criminal Justice and Behavior, 29(1),
87-109. (03.22)
Burdon, W. M., Kilian, T. C., Koutsenok, I., & Prendergast,
M. L. (2001). Treating substance-abusing sex offenders in a correctional
environment: Lessons for the California experience. Offender
Substance Abuse Report, 1(1), 3-4, 11-12. (03.16)
Burdon, W. M., Roll, J. M., Prendergast, M. L., & Rawson,
R. (2001). Drug courts and contingency management. Journal
of Drug Issues, 31(1), 73-90. (27.14)
Campos, M., Prendergast, M. L., Evans, W., & Martinez, J.
(2003). The California Department of Corrections Drug Reduction
Strategy Project. Offender Substance Abuse Report, 3(4),
49-50, 59-60. (03.32)
Carpenter, C. L., Kowalewski, M. R., Longshore, D., Annon, K.,
& Anglin, M. D. (1996). Prevalence of HIV-1 among recent arrestees:
Accessing a proxy group for hidden populations. Unpublished manuscript,
University of California, Los Angeles, Drug Abuse Research Center.
(01.26)
Carpenter, C. L., Longshore, D., Annon, K., Annon, J. J., &
Anglin, M. D. (1999). Prevalence of HIV-1 among recent arrestees
in Los Angeles County: Serial cross-sectional study, 1991 to 1995.
Journal of Acquired Immune Deficiency Syndromes and Human
Retrovirology, 21(2), 172-178. (01.37)
Carroll, K. M., Farentinos, C., Ball, S. A., Crits-Cristoph, P.,
Libby, B., Morganstern, J., Obert, J. L., Polcin, D., & Woody,
G. E. (2002). MET meets the real world: Design issues and clinical
strategies in the clinical trials network. Journal of Substance
Abuse Treatment, 23(2), 73-80. (13.39)
Chapman, M.A., Roll, J.M., Park, S., Galloway, M.P. (2003). Extracellular
glutamate decrease in accumbens following cued food delivery.
Neuroreport, 14(7), 991-4. (20.24)
Chefer, S. I., London, E. D., Koren, A. O., Pavlova, O. A., Kurian,
V., Kimes, A. S., Horti, A. G., & Mukhin, A. G. (2003). Graphical
analysis of 2-[F-18]FA binding to nicotinic acetylcholine receptors
in rhesus monkey brain. Synapse, 48(1), 25-34. (30.25)
Chermack, S. T., Roll, J. M., Reilly, M. P., Davis, L., Kilaru,
U., & Grabowski, J. (2000). Comparison of patient self-reports
and urinalysis results obtained under naturalistic methadone treatment
conditions. Drug and Alcohol Dependence, 59(1), 43-49.
(10.38)
Chou, C. P., Hser. Y., & Anglin, M. D. (1998). Interaction
effects of client and treatment program characteristics on retention:
An exploratory analysis using hierarchical linear models. Substance
Use and Misuse, 33(11), 2281-2301. (24.5)
Chou, C. P., Hser, Y., & Anglin, M. D. (2003). Longitudinal
treatment effects among cocaine users: A growth curve modeling
approach. Substance Use and Misuse, 38(9), 1323-1343.
(04.59)
Chou, C. P., Hser, Y., & Anglin, M. D. (1996). Pattern reliability
of narcotics addicts' self-reported data: A confirmatory assessment
of construct validity and consistency. Substance Use and Misuse,
31(9), 1189-1216. (12.6)
Chung, T., Martin, C. S., Grella, C. G., Winters, K. C., Abrantes,
A. M., & Brown, S. A. (2003). Course of alcohol problems in
treated adolescents. Alcoholism: Clinical and Experimental
Research, 27(2), 253-261. (05.19)
Collins, C., Grella, C. E., & Hser, Y. (2003). Effects of
gender and level of parental involvement among parents in drug
treatment. American Journal of Drug and Alcohol Abuse, 29(2),
237-261. (14.15)
Compton, P. A., Anglin, M. D., Khalsa-Denison, M. E., & Paredes,
A. (1996). The d2 dopamine receptor gene, addiction and personality:
Clinical correlates in cocaine abusers. Biological Psychiatry,
39(4), 302-304. (04.28)
Compton, P. A., Charuvastra, V. C., Kintaudi, P. , & Ling,
W. (2000). Pain responses in methadone-maintained opioid abusers.
Journal of Pain and Symptom Management, 20(4 ), 237-245.
(29.17)
Compton, P. A., Charuvastra, V. C., & Ling, W. (2001). Pain
intolerance in opioid-maintained former opiate addicts: effect
of long-acting maintenance agent. Drug and Alcohol Dependence,
63(2), 139-146. (29.7)
Compton, P. A., Darakjian, J., & Miotto, K. (1998). Screening
for addiction in patients with chronic pain and "problematic"
substance use: evaluation of a pilot assessment tool. Journal
of Pain and Symptom Management, 16(6), 355-363. (13.26)
Conner, B. T., Stein, J. A., Longshore, D., & Stacy, A. W.
(1999). Associations between drug abuse treatment and cigarette
use: evidence of substance replacement. Experimental and Clinical
Psychopharmacology, 7(1), 64-71. (13.20)
Cooper, L., Brown, V. B., & Anglin, M. D. (1989). Multiple
diagnosis: Aspects and issues in substance abuse. Los Angeles:
Drug Abuse Information and Monitoring Project, UCLA Drug Abuse
Research Center. (15.1)
Cooper, L., Liberman, D., Tucker, D., Neuchterlein, K. H., Tsuang,
J., & Barnett, H. L. (1999). Neurocognitive deficits in the
dually diagnosed with schizophrenia and cocaine abuse. Psychiatric
Rehabilitation Skills, 3(2), 231-245. (15.8)
Corby, E. A., Roll, J. M., Ledgerwood, D. M., & Schuster,
C. R. (2000). Contingency management interventions for treating
the substance abuse of adolescents: A feasibility study. Experimental
and Clinical Psychopharmacology, 8(3), 371-376. (27.3)
Covey, L. S., Joseph, A. M., & Shoptaw, S. (2003). Response:
Getting tough with smoking. Science & Practice Perspectives,
2(1), 40-42. (17.10)
Crevecoeur, D., Finnerty, B. A., & Rawson, R. (2002). Los
Angeles County Evaluation System (LACES): Bringing accountability
to alcohol and drug abuse treatment through a collaboration between
providers, payers, and researchers. Journal of Drug Issues, 32(3),
865-880. (13.33)
Last updated - 02/11/2010